Loading patent…
OwnerZeina Jouni, Bryan Hanley +1inventors
InventorsZeina Jouni, Bryan Hanley, Aedin Cassidy
Estimating the term…
The present disclosure relates methods of promoting phase II enzyme gene expression in a pediatric subject, comprising administering to the subject a nutritional composition comprising an effective amount of a phytonutrient. The disclosure also relates to methods of promoting phase II enzyme gene expression in a prenatal infant, comprising administering to a female pregnant with the prenatal infant an effective amount of a composition comprising phytonutrients. The disclosure further relates to a method of promoting phase II enzyme gene expression in a prenatal infant, comprising administering to a female pregnant with the prenatal infant an effective amount of a composition comprising phytonutrients.
A method of promoting phase II enzyme gene expression in a pediatric subject, comprising administering to the subject a nutritional composition comprising an effective amount of a phytonutrient.
A method of promoting phase II enzyme gene expression in an infant nursing from a lactating female, comprising administering to the lactating female a composition comprising an effective amount of a phytonutrient, and feeding the infant with breast milk from the lactating female.
-19. (canceled)
A method of promoting phase II enzyme gene expression in a prenatal infant, comprising administering to a female pregnant with the prenatal infant an effective amount of a composition comprising phytonutrients.
21-23. (canceled)
A milk-based nutritional composition, comprising a fat source, a carbohydrate source, a protein source and a phytonutrient source, wherein the composition is capable of promoting phase II enzyme gene expression in a pediatric subject.
25-42. (canceled)
A supplement for a pregnant or lactating female, comprising a phytonutrient source, wherein the supplement is capable of promoting phase II enzyme gene expression in:
44-46. (canceled)
Dependencies are inferred from the claim text.